LPL Financial’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDL
MI
LPL Financial's CRDL Position: Q3 2026 in Review
LPL Financial increased its Cardiol Therapeutics (CRDL) stake by 40% in Q3 2026, buying an estimated $8.03K and bringing the position to 17,650 shares worth $29.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6184.
LPL Financial first reported a position in CRDL in Q2 2022 and has held it in 6 quarters since. 59 funds tracked by Wall St. Rank hold CRDL as of Q3 2026.
- LPL Financial held 17,650 shares of Cardiol Therapeutics worth $29.3K as of Q3 2026.
- LPL Financial bought 5,040 Cardiol Therapeutics shares in Q3 2026, an estimated $8.03K.
- Cardiol Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #6184 holding.
- LPL Financial first reported a position in Cardiol Therapeutics in Q2 2022 and has held it in 6 quarters since.
- 59 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2026.
Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.